Atacicept Shows Promise in Lupus Treatment Trials
Tanezumab Promising for OA Pain; Plus Filgotinib Investigated for Psoriatic Arthritis
AMA Opposes Merger of CVS & Aetna
Adalimumab Appears Safe for Treating Pediatric Patients with Autoimmune Disease
Insys to Pay $150 Million to Settle U.S. Opioid Kickback Probe
EU Grants Marketing Authorization for Hyrimoz; Plus FDA Rejects New Drug Application for Buprenorphine Sublingual Spray
Long-Term Apremilast Promising for Psoriatic Arthritis
Pfizer-Lilly Pain Drug Meets Late-Stage Trial Goals
Upadacitinib Promising for RA Patients
- 1
- 2
- 3
- …
- 83
- Next Page »